Money mergers medicine shape healthcare quality as leaders weigh consolidation benefits for value-based care and clinical outcomes.

Billions of dollars have been raised for medical research because human genes can be patented so, when breakthroughs occur, investors make money. But early this week New York Federal Judge Robert W.

The biotech industry has been shaken to its financial foundations by a judge's decision that human genes cannot be patented any more. We find out what could happen to the new world of genetic medicine ...